Is Precision Medicine the Answer to Existing Challenges in Oncology?

11 May 2022

According to the World Health Organization (WHO) studies, cancer is the leading cause for deaths worldwide. In 2020 alone, cancer claimed close to 10million lives. 

Standard therapies, such as chemotherapy or radiotherapy, are only successful in a small percentage of patients because of disease heterogeneity.

Oncologists suggests that this limitation is largely due to the reason that malignancies can have a variety of hereditary origins and may express various proteins in different patients. This intrinsic diversity of the cancer disease has pushed researchers to look for precision and customized therapies and medical solutions.

Many initiatives are currently underway to collect precision and personalized medicine (PPM) data to describe molecular variations amongst cancer tumors.


Precision medicine works on the concept of detecting genetic variants that influence the clinical response to therapies. Unlike empiric medicine, precision medicine starts with analysis and testing of the patient to discover the targeted treatment.

Following the completion of the human genome project, great progress was made in describing the human epigenome, proteome, metabolome, and pharmacogenomics, resulting in the emergence of personalized healthcare for individuals, particularly cancer patients.

Furthermore, precision screening enables targeted therapy, which plays an important role in the treatment of cancer since it permits cancer cell development to be slowed by interfering with cancer-causing chemicals.

Precision Medicine in Oncology

Precision medicine is being applied to determine which tests and treatments are best for particular malignancies. Doctors may be able to assist the patients in the following ways using precision medicine:

• Determine who is at a higher risk for cancer

• Preventing some specific types of cancers

• Detect some malignancies early

• Correctly diagnose a specific form of cancer

• Choose the best treatment alternatives




Types of Cancer Where PPM is Relevant

It's critical to recognize that precision medicine isn't employed for every malignancy. However, it is hoped that one day, therapies will be tailored to each person's gene mutations in cancer. This is an area where a lot of studies are being done.

The following are some of the more frequent tumors for which personalized medicine is being utilized to aid treatment decisions:

• Colorectal cancer

• Breast cancer

• Lung cancer

• Various forms of leukemia

• Various types of lymphoma

• Melanoma

• Esophageal cancer

• Stomach cancer

• Ovarian cancer

Global Discussions on Precision Medicine

On global level, precision medicine therapies and its applications are gaining massive acceptance and popularity; not just among oncologists but, other healthcare experts. The PrecisionMed Exhibition and Summit is one such global event that allows all stakeholders to come together and interact to learn, understand, and share their views on precision medicine.

The only dedicated precision medicine event held in the middle east, PrecisionMed expo 2022 is set for 24th and 25th of May this year in Dubai. Medical experts, scientists, doctors, pharmaceutical owners, and more from all over the world would be attending this decorated event to listen as well as speak on different topics around precision medicine.

The objective behind this exhibition is to discover how precision medicine is taking healthcare from “one size fits all” to a targeted approach.




BIS Research is one of the participants at this event this year, represented by its team of healthcare analysts, who’d be talking about the role of precision medicine in oncology, under liquid biopsy.

Apart from the speaker opportunity BIS Research will also be holding a booth (#D06) at the event where the team of healthcare analysts will be available to interact with different healthcare stakeholders and explain them the company’s approach and capabilities in providing market intelligence to companies engaged in precision medicine market.

For more details on the event visit here

Conclusion

The customization of disease-based therapeutics evolved as a result of a mix of technological advancements, healthcare digitalization, and government funding.

Precision medicine's growth will have a significant influence on the biopharmaceutical business, as well as many participants ranging from biopharma to diagnostics firms.

However, there are certain disadvantages. Access to the most up-to-date precision medicine studies may be limited. There is still much to learn regarding how precision medicine may be utilized to treat cancer. Researchers are attempting to fill in the blanks.

Here’s a sample of a detailed report on oncology precision medicine market that you can refer to for more details.

Clinical trials in precision medicine are frequently only available at major cancer centers. As a result, an individual’s prospects of participating in clinical studies may be reduced. Even when personalized medicine is accessible outside of a clinical trial, it isn't usually utilized to its full potential.

 
 

Request a Sample

 

Twitter Feeds

 

OUR CLIENTS